Xisi Guo leaves Optomed’s Board of Directors

Report this content

Optomed Plc Stock Exchange Release 22 July 2022 at 17:00, Helsinki

Xisi Guo leaves Optomed’s Board of Directors

Xisi Guo has decided to leave the Board of Directors of Optomed 19 August 2022 as he decided to leave his position at Cenova Capital, Optomed’s largest shareholder. After the change, Optomed’s Board of Directors will consist of four members: Petri Salonen (chair), Seppo Mäkinen, Reijo Tauriainen and Anna Tenstam.

 

According to Optomed’s articles of association, Optomed’s Board shall consist of at least five members. Consequently, Optomed’s Board will convene an extraordinary general meeting to appoint a new board member. The invitation to the extraordinary general meeting will be publishes separately.

 


Optomed Plc



Further enquiries

Petri Salonen, Chairman, Optomed Plc, petri.salonen@optomed.com

 

 

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.
www.optomed.com

Subscribe